Campo J, Cano J, del Romero J, Hernando V, del Amo J, Moreno S. Role of the dental surgeon in the early detection of adults with underlying HIV infection / AIDS. Med Oral Patol Oral Cir Bucal. 2012 May 1;17 (3):e401-8.

doi:10.4317/medoral.17527

http://dx.doi.org/doi:10.4317/medoral.17527

1. Pérez-Hoyos S, Ferreros I, del Amo J, Muga R, del Romero, de Olalla PG, et al. Survival and progresión to AIDS in a seroconverter cohorte in the post-highly active antirretroviral therapy era: effectiveness goes on. AIDS. 2006; 20:289-91.
http://dx.doi.org/10.1097/01.aids.0000202651.41397.db
PMid:16511426

2. Gatell JM, Zulaica D, Robledo T, Del Romero J. Como promover y facilitar el diagnóstico precoz de la infección por el VIH-1; Papel de los odontólogos. Cient Dent. 2010;7(1):65-8.

3. Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T et al. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS. 2007;18:312–7.
http://dx.doi.org/10.1258/095646207780749709
PMid:19244539

4. Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med. 2008; 9:6-12.
http://dx.doi.org/10.1111/j.1468-1293.2008.00584.x
PMid:18557863

5. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20:1447-50.
http://dx.doi.org/10.1097/01.aids.0000233579.79714.8d
PMid:16791020

6.Vigilancia epidemiológica del VIH en España. Valoración de los nuevos casos de VIH en España a partir de los sistemas de notificación de las CCAA. Periodo 2003-2009 [Acceso 14 Diciembre 2010]. Disponible en http://www.isciii.es/htdocs/pdf/nuevos_diagnosticos_ccaa.pdf

7. Sobrino-Vegas P, García-San Miguel L, Caro-Murillo AM, Miro JM, Viciana P, Tural C, et al. Delayed diagnosis of HIV infection in a multicenter cohort: Prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res. 2009 Mar;7(2):224-30.
http://dx.doi.org/10.2174/157016209787581535
PMid:19275591

8. Gazzard B, Clumeck N, d’Arminio Monforte A, Lundgren JD. Indicator disease-guided testing for HIV-the next step for Europe?. HIV Medicine. 2008;9: 34-40.
http://dx.doi.org/10.1111/j.1468-1293.2008.00592.x
PMid:18557871

9. Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12:61-4.
http://dx.doi.org/10.1111/j.1468-1293.2010.00857.x
PMid:20561080

10. Owens DK, Sundaram V, Lazzeroni LC, Douglass LR, Tempio P, Holodniy M, et al. HIV testing of at risk patients in a large integrated health care system. J Gen Intern Med. 2007;22:315-20.
http://dx.doi.org/10.1007/s11606-006-0028-9
PMid:17356961    PMCid:1824727

11. Chou R, Huffman LH, Fu R, Smits AK, Korthius PT, US Preventive Services Task Force. Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;143:55-73.
PMid:15998755

12. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents and pregnant women in heath care settings. MMWR Recomm Rep. 2006; 55:1-17.

13. World Health Organization (WHO).Guidance on provider-initiated HIV testing and counselling in health facilities. [Acceso 14 de diciembre de 2010]. Disponible en: http://whqlibdocwhoint/publications/2007/9789241595568_eng pfd 2007 www.bma.org.uk/ap.nsf/Content/stiup06 March 2006.

14. UK National Guidelines for HIV testing 2008. [Acceso 14 de diciembre de 2010] Disponible en: http://www.bhiva.org

15. Qaseem A, Snow V, Shekelle P, Hopkins R, Owens DK, Clinical Efficacy Assessment Subcommittee, American College of Physicians. Screening for HIV in Health Care Settings: A guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med. 2009;150:125-31.
PMid:19047022

16. ECDC Guidance. HIV Testing: increasing uptake and effectiveness in the European Union. [Acceso 14 de diciembre de 2010]. Disponible en: http://ecdc.europa.eu/en/publications/Publications/101129_GUI_HIV_testing.pdf

17. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352:570-85.
http://dx.doi.org/10.1056/NEJMsa042657
PMid:15703422

18. HIV infection screening in France. Screening strategies. [Acceso 7 de febrero de 2011] Disponible en: http://www.has-sante.fr, 2009

19. Moreno S, Ordobas M, Sanz JC, Ramos B, Astray J, Ortiz M, et al. Prevalencia de infección por VIH no diagnosticada en la población de Madrid: evidencia de la necesidad de programas de diagnóstico eficaces. II Congreso Nacional de GESIDA, 30 Nov 2010. Enfermedades Infecciosas y Microbiología Clínica. 2010;28(2):3.

20. National Center for Health Statistics National Health and Nutrition Examination Survey (NHANES) 1999-2004.[Acceso 14 de diciembre de 2010]. Disponible en: http://www.cdc.gov/nchs/nhanes.htm

21. Vernillo AT, Caplan AL. Routine HIV Testing in Dental Practice: Can we cross the rubicon?. J Dent Educ. 2007;71:1534-9.
PMid:18096878

22. Shiboski CH, Patton LL, Webster-Cyriaque JY, Greenspan D, Traboulsi RS,Ghannoum M,et al. Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group. The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints. J Oral Pathol Med. 2009 Jul;38(6):481-8.
http://dx.doi.org/10.1111/j.1600-0714.2009.00749.x

23. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol. 1994;77:344-9.
http://dx.doi.org/10.1016/0030-4220(94)90195-3

24. Patton LL, McKaig RG, Eron JJ Jr, Lawrence HP, Strauss RP. Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load. AIDS. 1999;13:2174-6.
http://dx.doi.org/10.1097/00002030-199910220-00026
PMid:10546876

25. Pindborg JJ. Classification of oral lesions associated with HIV infection. Oral Surg Oral Med Oral Pathol. 1989;67:292-5.
http://dx.doi.org/10.1016/0030-4220(89)90358-7

26. Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, González-Ramírez I, Ponce-de-León S. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico. Medicine (Baltimore). 2003;82:39-50.
http://dx.doi.org/10.1097/00005792-200301000-00004

27. Greenspan D, Gange S, Phelan J, Navazesh M, Alves ME, MacPhail LA et al. Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res. 2004;83: 145-50.
http://dx.doi.org/10.1177/154405910408300212
PMid:14742653

28. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet. 2001;357:1411-2.
http://dx.doi.org/10.1016/S0140-6736(00)04578-5

29. Classification and diagnostic criteria for oral lesions in HIV-infection. EC-Clearinghouse on oral problems related to HIV infection and WHO collaboration centre on oral manifestations of the immunodeficiency virus. J Oral Pathol Med. 1993;22:289-91.
http://dx.doi.org/10.1111/j.1600-0714.1993.tb01074.x
PMid:8229864

30. Bhayat A, Yengopal V, Rudolph MJ, Nemutandani MS. Predicting HIV in a public dental facility using Group I Oral Lesions. SADJ. 2008;63:538-43.
PMid:19322964

31. Itula PF, Mackenzie SB, Lewis K, Mortimer PP. Orofacial manifestations and seroprevalence of HIV infection in Namibian dental patients. Oral Dis. 1997;3:S51-3.
PMid:9456657

32. Robinson PG, Challacombe SJ, Sheiham A. Oral examination: a screening tool for HIV infection?. Sex Transm Inf. 1998;74:345-8.
http://dx.doi.org/10.1136/sti.74.5.345
PMid:10195030    PMCid:1758150

33. Bhayat A, Yengopal V, Rudolph M. Predictive value of group I oral lesions for HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:720-3.
http://dx.doi.org/10.1016/j.tripleo.2009.11.019
PMid:20303299

34.Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H;Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America.Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR Recomm Rep. 2009;58:1-207.
PMCid:2821196

35.- Glick M. Rapid HIV testing in the dental setting. J Am Dent Assoc.2005;136:1206-8.
PMid:16196224

36.- Debattista J, Bryson G, Roudenko N, Dwyer J, Kelly M, Hogan P, et al. Pilot of noninvasive (oral fluid) testing for HIV within a clinical setting. Sex Health. 2007;4:105-9.
http://dx.doi.org/10.1071/SH07014
PMid:17524288

37.-Wesolowski LG, MacKellar DA, Facente SN, Dowling T, Ethridge SF, Zhu JH, et al. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS. 2006;20:1661-6.
http://dx.doi.org/10.1097/01.aids.0000238413.13442.ed
PMid:16868448

38.-Hunt AJ, Connell J, Christofinis G, Parry JV, Weatherburn P, Hickson FC, et al. The testing of saliva samples for HIV-1 antibodies: reliability in a non-clinic setting. Genitourin Med. 1993;69:29-30.
PMid:8444477    PMCid:1195005

39.-Bhore AV, Sastry J, Patke D, Gupte N, Bulakh PM, Lele S, et al. Sensitivity and specificity of rapid HIV testing of pregnant women in India. Int J STD AIDS. 2003;14:37-41.
http://dx.doi.org/10.1258/095646203321043246
PMid:19244539

40.-Patton LL, Santos VA, McKaig RG, Shugars DC, Strauss RP. Education in HIV risk screening, counseling, testing and referral: survey of U.S. dental schools. J Dent Educ. 2002;66:1169-77.
PMid:12449212